Lyka Labs Ltd - 500259 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31st March, 2019 received from M/s. Sharex Dynamic (India) Pvt. Ltd, Registrar and Share Transfer Agent of Lyka Labs Limited. This is for your information and record. Lyka Labs Ltd - 500259 - Shareholding for the Period Ended March 31, 2019
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here LYKA LABS LTD. - 500259 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For The Half Year Ended On 31St March, 2019
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate, duly signed by Authorized Signatory of M/s. Sharex Dynamic (India) Private Limited, Share Transfer Agent of Lyka Labs Limited ('the Company') and by the Company Secretary and Compliance Officer of the Company for the half year ended 31st March, 2019. Lyka Labs Ltd - 500259 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Raj TrivediDesignation :- Company Secretary and Compliance Officer LYKA LABS LTD. - 500259 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Lyka Labs Ltd has submitted to BSE a copy of Clarification is enclosed. LYKA LABS LTD. - 500259 - Closure of Trading Window
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015, we wish to inform that the trading window for dealing in the equity shares of the Company for designated persons and their immediate relatives shall remain closed with immediate effect (i.e. 4th April, 2019) till 48 hours after the declaration of Financial Results for the quarter and year ended 31st March, 2019 (both days inclusive). The date of Board Meeting for considering the said Financial Results for the quarter and year ended 31st March, 2019 shall be intimated in due course. This is for your information and records. LYKA LABS LTD. - 500259 - Clarification Sought on Price Movement
The Exchange has sought clarification from the company on April 3, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Lyka Labs Ltd - 500259 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
We wish to inform you that the Board of Directors of the Company have considered and approved/adopted the revised code of practice and procedure for fair disclosure of Unpublished price sensitive information which also includes the policy for determining the 'Legitimate purpose'. The Revised/Amended Code of practice and procedure for fair disclosure of Unpublished price sensitive information is effective from 1st April, 2019 and shall be made available on the Company's website at www.lykalabs.com. This is for your information and records. LYKA LABS LTD. - 500259 - One Time Settlement
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company's account was classified as Non-Performing Asset by Bank of Maharashtra ('The Bank') with effect from 1st May, 2016. The outstanding amount payable to the Bank as on 30th September, 2018 was Rs. 16.46 crores. Thereafter, the Company entered into One Time Settlement with the Bank and arranged to make upfront payment of Rs. 11.00 Crores as settlement amount and Rs. 6.49 lakh (including GST of Rs. 0.99 lakh) as processing fees to the Bank pursuant to which the Bank has released its mortgage charge on the immovable property of the Company situated at Gala No. 101 to 108 and 150 to 154, Shiv Shakti Industrial Estate, M V Road, Marol, Andheri (East), Mumbai 400059 and is also in the process of partly releasing the pledged shares held by the Promoters of the Company. Further, an amount of Rs. 33 lakhs being the interest for delayed period along with revalidation fees amounting to Rs.2.75 lakhs + GST is payable to the Bank by 30th April 2019 and on payment of said amount the Bank will release the pending pledged shares held by the Promoters of the Company. This is for your information and record. Lyka Labs Ltd - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the information regarding loss/misplacement of share certificate received from a shareholder of the Company.